The new therapy includes the oral medication Xeljanz (tofacitinib) -- a drug already approved for use in rheumatoid arthritis patients that dampens the body's immune response -- and ultraviolet-B light therapy.
From: https://www.webmd.com/skin-problems-and-treatments/news/20180205/new-treatment-could-be-breakthrough-for-vitiligo?src=RSS_PUBLIC
No comments:
Post a Comment